Subthalamic Stimulation Improves Short-Term Satisfaction with Life and Treatment in Parkinson's Disease.

The effect of subthalamic stimulation (STN-DBS) on patients' personal satisfaction with life and their Parkinson's disease (PD) treatment is understudied, as is its correlation with quality of life (QoL). Therefore, we tested the hypothesis that STN-DBS for PD enhances satisfaction with life and treatment. In a prospective, multicenter study with a 6-month follow-up involving 121 patients, we measured the main outcomes using the Satisfaction with Life and Treatment Scale (SLTS-7).

The New Satisfaction with Life and Treatment Scale (SLTS-7) in Patients with Parkinson's Disease.

Background: The satisfaction with life and, in particular, with treatment in Parkinson's disease (PD) is understudied.

Objective: To explore a new 7-item rating tool assessing satisfaction with life and treatment (SLTS-7) in PD.

Methods: In this cross-sectional, multi-center study, including patients screened for advanced therapies, psychometric characteristics of the SLTS-7 were analyzed.

Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease.

Background: The effects of subthalamic stimulation (subthalamic nucleus-deep brain stimulation, STN-DBS) on impulsive and compulsive behaviours (ICB) in Parkinson's disease (PD) are understudied.

Objective: To investigate clinical predictors of STN-DBS effects on ICB.

Methods: In this prospective, open-label, multicentre study in patients with PD undergoing bilateral STN-DBS, we assessed patients preoperatively and at 6-month follow-up postoperatively.